SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 23 filers reported holding SOLENO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $20,000 | -16.7% | 105,481 | 0.0% | 0.00% | – |
| Q1 2022 | $24,000 | -44.2% | 105,481 | 0.0% | 0.00% | – |
| Q4 2021 | $43,000 | -55.7% | 105,481 | 0.0% | 0.00% | – |
| Q3 2021 | $97,000 | -19.2% | 105,481 | 0.0% | 0.00% | – |
| Q2 2021 | $120,000 | -84.3% | 105,481 | -82.6% | 0.00% | – |
| Q1 2021 | $763,000 | -40.9% | 605,362 | -9.6% | 0.00% | – |
| Q4 2020 | $1,292,000 | -18.0% | 669,610 | +6.7% | 0.00% | – |
| Q3 2020 | $1,575,000 | +89.8% | 627,686 | +68.0% | 0.00% | – |
| Q2 2020 | $830,000 | +634.5% | 373,574 | +689.2% | 0.00% | – |
| Q1 2020 | $113,000 | +63.8% | 47,333 | +100.4% | 0.00% | – |
| Q4 2019 | $69,000 | +187.5% | 23,618 | +103.1% | 0.00% | – |
| Q1 2019 | $24,000 | +20.0% | 11,630 | 0.0% | 0.00% | – |
| Q4 2018 | $20,000 | -20.0% | 11,630 | 0.0% | 0.00% | – |
| Q3 2018 | $25,000 | -7.4% | 11,630 | 0.0% | 0.00% | – |
| Q2 2018 | $27,000 | – | 11,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clayton Partners LLC | 100,000 | $167,000 | 0.19% |
| Bollard Group LLC | 2,288 | $4,000 | 0.00% |